CHEK2 and neoplasm: Moreover, in the Abdelfattah et al.29 scRNA-seq data we also observed an a gene signature enrichment of the antigen presentation pathway (p = 1e−11) in low CHEK2 expressing tumor cells as compared to the high CHEK2 expressing tumor cells (Supplementary Fig. 3c).